Pulmonary Zygomycosis in a Non-neutropenic Patient With Myelodysplastic Syndrome on Lenalidomide

References

1. 1.↵
   1. Vallet S,
   2. Palumbo A,
   3. Raje N,
   4. Boccadoro M,
   5. Anderson KC

   . Thalidomide and lenalidomide: mechanism-based potential drug combinations. Leuk Lymphoma 2008;49(7):1238-1245.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Pyrgos V,
   2. Shoham S,
   3. Walsh T

   . Pulmonary zygomycosis. Semin Respir Crit Care Med 2008;29(2):111-120.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Roden MM,
   2. Zaoutis TE,
   3. Buchanan WL,
   4. Knudsen TA,
   5. Sarkisova TA,
   6. Schaufele RL,
   7. et al

   . Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005;41(5):634-653.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Mele L,
   2. Ricci P,
   3. Nosari A,
   4. Tonso A,
   5. Fianchi L,
   6. Cudillo L,
   7. Pagano L

   . Invasive fungal infection in patients with myelodysplastic syndrome: a report of twelve cases. Leuk Lymphoma 2002;43(8):1613-1617.

   OpenUrlPubMed
5. 5.↵
   1. Pagano L,
   2. Girmenia C,
   3. Mele L,
   4. Ricci P,
   5. Tosti ME,
   6. Nosari A,
   7. et al

   . Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 2001;86(8):862-870.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Bartlett JB,
   2. Dredge K,
   3. Dalgleish AG

   . The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer 2004;4(4):314-322.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Keijzer A,
   2. van der Valk P,
   3. Ossenkoppele GJ,
   4. van de Loosdrecht AA

   . Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha. Haematologica 2006;91(Suppl 12):e51.

   OpenUrl
8. 8.↵
   1. Glazer M,
   2. Nusair S,
   3. Breuer R,
   4. Lafair J,
   5. Sherman Y,
   6. Berkman N

   . The role of BAL in the diagnosis of pulmonary mucormycosis. Chest 2000;117(1):279-282.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Kontoyiannis DP,
   2. Lewis RE

   . Invasive zygomycosis: update on pathogenesis, clinical manifestations and management. Infect Dis Clin North Am 2006;20(3):581-607.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Rogers TR

    . Treatment of zygomycosis: current and new options. J Antimicrob Chemother 2008;61(Suppl 1):i35-i40.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Tedder M,
    2. Spratt JA,
    3. Anstadt MP,
    4. Hegde SS,
    5. Tedder SD,
    6. Lowe JE

    . Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994;57(4):1044-1050.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Lee FY,
    2. Mossad SB,
    3. Adal KA

    . Pulmonary mucormycosis: the last 30 years. Arch Intern Med 1999;159(12):1301-1309.

    OpenUrlCrossRefPubMedWeb of Science